Thrombolysis of symptomatic proximal vein thrombosis research hub

(22138) A randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of BAY 3018250 in patients with symptomatic proximal deep vein thrombosis

This study is testing a new medicine, BAY 3018250, for blood clots in deep veins (DVT) in the legs. We want to see if it helps break down clots and reduce leg pain, while also checking for any serious side effects like bleeding.